EDGAR Filing Documents for 0001104659-17-031339

Form 8-K - Current report:

SEC Accession No. 0001104659-17-031339

Filing Date

2017-05-10

Accepted

2017-05-10 07:38:41

Documents

Period of Report

2017-05-10

Items

Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-12761_18k.htm	8-K	31571
2	EX-99.1	a17-12761_1ex99d1.htm	EX-99.1	168979
3	EX-99.2	a17-12761_1ex99d2.htm	EX-99.2	11514
4	GRAPHIC	g127611moi001.jpg	GRAPHIC	5085
5	GRAPHIC	g127611mm01i001.jpg	GRAPHIC	5085
	Complete submission text file	0001104659-17-031339.txt		227680

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY

Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000

Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)